Hikma Pharma launches Basilea's hospital antibiotic Zevtera in Saudi Arabia

Basilea Pharmaceutica Ltd. announced that its partner Hikma Pharmaceuticals LLC has launched Basilea's hospital antibiotic Zevtera (ceftobiprole) in Saudi Arabia.

More From BioPortfolio on "Hikma Pharma launches Basilea's hospital antibiotic Zevtera in Saudi Arabia"